DoD Ovarian Cancer Translational Leverage Award

The summary for the DoD Ovarian Cancer Translational Leverage Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD Ovarian Cancer Translational Leverage Award: The OCRP Translational Leverage Award mechanism supports the leveraging of existing human-based ovarian cancer resources in translational research to address high-impact research ideas or unmet needs in ovarian cancer. Many ovarian cancer resources are confined to investigators labs where they were first developed and are not always available for use by others. Often, resources are not leveraged for maximum use beyond the original source, and as a result, investigators expend time and money to duplicate those resources. This award mechanism is focused on leveraging existing human-based resources that will ultimately benefit ovarian cancer research. These existing resources are expensive to generate, maintain, and make available to other investigators, but they may have broad applicability across many different types of research questions. Examples of human-based resources include, but are not limited to, biorepositories of clinical specimens, existing tissue banks, epidemiological resources, clinical databases, laboratory expertise, large transcriptome or proteome datasets, and databases of clinical data and/or metadata.